Company Profile

TungTakSim Biotech

Shenzhen TungTakSim Biotech Co., Ltd. is a research-driven company dedicated to life sciences and collaborative academic research. The company is committed to advancing the translation of traditional herbal practices into modern life science applications. Starting from long-term real-world observations and supported by clinical trials, peer-reviewed publications, independent third-party laboratory reports, animal studies, and mechanistic research, the company has established a verifiable, reproducible, and translatable scientific research framework. Its research focuses on major medical challenges, including neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), pathogen inhibition, antimicrobial resistance and treatment outcomes, immune regulation, anti-hemolytic mechanisms, and the restoration of biological homeostasis. Rather than operating as a conventional product-oriented company, Shenzhen Tongdexin Biotech is founded on the holistic principles of Eastern medicine and seeks to reinterpret the scientific value of herbal nutrition through the language and methodology of modern biomedicine. The company strives to achieve breakthrough research in the fields of anti-infective strategies, immune reconstruction, organ protection, and regenerative life sciences. Looking ahead, Shenzhen Tongdexin Biotech will continue to collaborate with universities, hospitals, research institutions, and leading scientific experts to promote the scientific validation, standardization, and internationalization of herbal nutrition research.
TungTakSim Biotech
About Tongdexin
Focus on Life Research and Collaboration
Five Research Paths
From Mechanism Verification to Clinical Translation
Vision and Goals
Reverify the Value of Traditional Chinese Medicine with Modern Science
Achievement Report
Phased Achievements and Research Path Overview

Submit Request

Please submit your information, and we will respond as soon as possible

TungTakSim Biotech Overview of Achievements

TungTakSim Biotech Partner Institutions

Davis-Raynor
Thiel-Dietrich
Koepp-Emmerich
Quitzon Group
Lang, Strosin and Jenkins
Email